Trial description:
Real world UK use of Tyrosine Kinase Inhibitors (TKIs): A Retrospective description of manaGement pathways, clinical responses and compliance with 2013 European LeukemiaNeT (ELN) recommendations for Chronic Myeloid Leukemia (CML)
Contact name:
Dr Brian Huntley
Trial start date:
Tuesday, January 12, 2016
Trial end date:
Wednesday, August 8, 2018
Trial tumour type:
Haematological
Show on Radiotherapy:
No
